Status:
UNKNOWN
Analysis of Biopsies With Antibody Mediated Rejection According to the Therapy Response
Lead Sponsor:
Thomas Mueller
Conditions:
Antibody-mediated Rejection
Eligibility:
All Genders
18+ years
Brief Summary
In adult kidney transplant recipients a therapy-responder and non-responder phenotype by antibody mediated rejection will be precisely defined according to clinical and histological characteristics su...
Eligibility Criteria
Inclusion
- Kidney transplant patients at the University Hospital of Zurich between 01.01.2008 - 31.12.2016 with histologically suspected or confirmed ABMR
- Written consent for further use of data for research purposes
Exclusion
- Age at transplantation \< 18 years
- Combined organ transplantation (incl. Kidney-Pancreas, Kidney-Liver, Kidney-Heart)
- Incomplete laboratory and/or clinical data
- Recurrence of the initial disease
- Insufficient Biopsy Material for NanoString Analysis
- Documented refusal of further data analysis for research purpose
Key Trial Info
Start Date :
February 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03430414
Start Date
February 15 2018
End Date
April 30 2018
Last Update
February 12 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.